SAS Output

21-OCT-2018 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1609-Rare Tumor, Comb Nivo/Ipi 1 Y 1 Nivolumab + Ipilimumab 707 529 404 71 9 3 3 01/30/2017 307 159
            529 404 71 9 3 3      
 
Yes A071102-GBM, adj TMZ +/- Veliparib 0 E Total Registrations   134 24 8 0 0 0 02/02/2015 356 146
            134 24 8 0 0 0      
 
    1 E Total Registrations   49 12 9 3 0 0 02/02/2015    
            49 12 9 3 0 0      
 
  A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib 0 E Total Registrations   35 3 0 0 0 0 02/22/2016 297 110
            35 3 0 0 0 0      
 
    1 E Total Registrations   5 0 0 0 0 0 02/22/2016    
            5 0 0 0 0 0      
 
  ARST1321-NonRhabdo STS,Pazopanib (PAZNTIS) 1 E Total Registrations   9 5 2 0 0 0 09/04/2015 262 118
            9 5 2 0 0 0      
 
  EAY131-MATCH 0 E Total Registrations   921 33 22 19 5 1 08/21/2015 370 207
            921 33 22 19 5 1      
 
    1 E Total Registrations   127 25 16 14 7 2 08/21/2015    
            127 25 16 14 7 2      
 
    2 E Total Registrations   8 1 0 0 0 0 08/21/2015    
            8 1 0 0 0 0      
 
    8 E Total Registrations   2 1 1 1 0 0 08/21/2015    
            2 1 1 1 0 0